Cost-effectiveness analysis of budesonide/formoterol (Symbicort(R)) as needed for mild asthma in Malaysia
Background Budesonide/formoterol (Symbicort(R)) as needed (PRN) is effective for the prevention of severe exacerbations in mild asthma. Objective This economic model evaluated the cost effectiveness of budesonide/formoterol PRN versus (1) a short-acting beta(2)-agonist (SABA) PRN and (2) maintenance...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
2021
|
| Subjects: | |
| Online Access: | View Fulltext in Publisher |